After Hours
$
4.71
Change
+0.02 +0.43%
Volume
Volume 17,876
Mar 27, 2023, 6:27 p.m.
Quotes are delayed by 20 min
Previous close
$ 4.63
$ 4.69
Change
+0.06 +1.30%
Day low
Day high
$4.55
$4.82

52 week low
52 week high
$4.12
$13.19

Market cap
$283.82M
Average volume
469,846
P/E ratio
N/A
Rev. per Employee
$101,102
EPS
-1.63
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on CRBU
-
Crispr Therapeutics Stock Gains on Hope for Sickle-Cell Gene Therapy
- Barron's Online
-
Gene-Editor Crispr Therapeutics CEO Sees Positive Catalysts Ahead
- Barron's Online
-
Intellia Stock Has Tumbled. There Are Issues With Gene-Editing Patents.
- Barron's Online
-
These 3 Funds Invest Like ARK But Didn’t Fall as Far
- Barron's Online
-
Pfizer and Beam Partner to Develop Treatments for 3 Genetic Diseases
- Barron's Online
-
Caribou Biosciences started at outperform with $36 stock price target at Oppenheimer
- Tomi Kilgore
-
Prime Is the Newest Gene Editing, and It's Getting Better
- Barron's Online
-
Caribou Biosciences started at buy with $30 stock price target at BofA Securities
- Tomi Kilgore
-
7 Companies Open for Trading. Here's How They Did.
- Barron's Online
Other News on CRBU
-
10-K: CARIBOU BIOSCIENCES, INC.
- Edgar Online - (EDG = 10Q, 10K)
-
Tradeweb Exchange-Traded Funds Update - September 2022
- Seeking Alpha
-
Caribou Biosciences (CRBU) Investor Presentation - Slideshow
- Seeking Alpha
-
Caribou Biosciences (CRBU) Corporate Presentation - Slideshow
- Seeking Alpha
-
Caribou Biosciences: Potential To Change CAR-T Landscape
- Seeking Alpha
-
Caribou Biosciences (CRBU) Corporate Presentation - Slideshow
- Seeking Alpha
-
HYMC, AXLA and EVLO among mid-day gainers
- Seeking Alpha
- Loading more headlines...
Press Releases on CRBU
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com